F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 117,014 shares at $22.46 ($2.7M) on 2022-09-13, disclosed to the SEC on 2022-09-15.
Open-market sale of $2.7M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.46 | 19,700 | $442K | 16.2% |
| 2 | $22.90 | 13,836 | $317K | 11.6% |
| 3 | $22.90 | 13,836 | $317K | 11.6% |
| 4 | $23.63 | 25,075 | $593K | 21.7% |
| 5 | $23.63 | 25,075 | $593K | 21.7% |
| 6 | $24.15 | 9,746 |
| $235K |
| 8.6% |
| 7 | $24.15 | 9,746 | $235K | 8.6% |
| Total | $23.35 avg | 117,014 | $2.7M | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |